About InvestorForum
Showcasing the Leading Growth Companies in Life Sciences
October 17-19, 2006
Palace Hotel, San Francisco
ORGANIZER: Biotechnology Industry Organization
SUPPORTING PARTNERS: BayBio, BIOCOM and BIOTECanada
MISSION: A national investor forum to explore investment trends and opportunities in life sciences, with a focus on public and venture-stage growth companies as well as those poised to join the growth “watch list” in 2007
PROGRAM: The BIO InvestorForum delivers a rich program that features corporate presentations and panel debates on the sweet spots and growth challenges facing the industry:
- Public and venture-stage company presentations
- Expert-led workshops on the latest market and investment opportunities with emphasis on drug and technology development
- One-on-one investor meetings
- Breakout sessions between presenting company executives and investors
- Premier opportunity to network with industry executives and investors focused exclusively on life sciences
TARGET AUDIENCE: Public and private equity investors, research analysts, investment bankers and senior-level industry executives focused on investment trends and business development opportunities in life sciences
Companies attend to:
- present company story to an audience of target investors
- meet one-on-one with new and current investors, analysts, investment bankers and other potential corporate partners
- hear candid panel discussions and keynotes by veteran investment and company executives
- network with peers, investors and potential partners attending the conference
- get the pulse on the current and proposed investment trends in life sciences
Investors attend to:
- hear from and meet with management of the top life sciences growth companies
- evaluate fresh investment opportunities including compatible, complementary and competitive companies
- attend candid panel discussions with leading clinical experts and company experts on the latest therapies and technologies in development
- get a ‘big picture’ overview of the industry and the issues affecting investments now and for 2007